Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
Go back to Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 110.20 +0.54 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.66 | 52 Week High | $18.39 | |||
| Open | $109.84 | 52 Week Low | $6.96 | |||
| Day High | $111.15 | P/E | N/A | |||
| Day Low | $108.74 | EPS | $-0.58 | |||
| Volume | 1,142,231 | |||||
